Unsupervised selection of RV144 HIV vaccine-induced antibody features correlated to natural killer cell-mediated cytotoxic reactions

HIV-1 vaccine injection has been shown less effective due to the diversity of antigens. Increasing the knowledge of the associations between immune system and virus would ultimately result in producing effective vaccines against HIV-1 virus. To increase the understanding of immunological information, computational models can be utilised to construct predictive models. The aim of this study is, therefore, to predict the effect of antibody features (IgGs) and primary Natural Killing (NK) cells' cytotoxic activities on RV144 vaccine recipients and to disclose the functional relationship between immune system and HIV virus. The RV144 vaccine data set contains 100 data samples in which 20 of them are the placebo samples and 80 of them are the vaccine injected samples. Each data sample has twenty antibody features that consist of features related to IgG subclass and antigen specificity. In this paper, five different unsupervised feature selection methods (USFSMs) are utilised in order to identify the discriminating antibody features as USFSMs are regarded as unbiased approach. Then, the support vector based methods are utilised to assess association between cellular cytotoxicity by Natural Killer (NK) cells and cells that release glycoprotein (gp)120 antibody. The results yield high correlation coefficient as much as 0.48 and 0.65 for classificationthe support vector regression (SVR) and classification (SVM) predictive models, respectively.

[1]  Deng Cai,et al.  Laplacian Score for Feature Selection , 2005, NIPS.

[2]  Hiroshi Motoda,et al.  Feature Selection for Knowledge Discovery and Data Mining , 1998, The Springer International Series in Engineering and Computer Science.

[3]  Lei Shi,et al.  Robust Spectral Learning for Unsupervised Feature Selection , 2014, 2014 IEEE International Conference on Data Mining.

[4]  Huan Liu,et al.  Feature Selection for Classification , 1997, Intell. Data Anal..

[5]  Punnee Pitisuttithum,et al.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. , 2006, The Journal of infectious diseases.

[6]  Vladimir Vapnik,et al.  An overview of statistical learning theory , 1999, IEEE Trans. Neural Networks.

[7]  N. Haigwood,et al.  Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys , 1999, Nature Medicine.

[8]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[9]  Ahmed Bouridane,et al.  Comparison of unsupervised feature selection methods for high-dimensional regression problems in prediction of peptide binding affinity , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[10]  Chris Bailey-Kellogg,et al.  Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees , 2015, PLoS Comput. Biol..

[11]  S. Plotkin.  Correlates of Protection Induced by Vaccination , 2010, Clinical and Vaccine Immunology.

[12]  Marco Cristani,et al.  Infinite Feature Selection , 2015, 2015 IEEE International Conference on Computer Vision (ICCV).

[13]  Tomer Hertz,et al.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2 , 2012, Nature.

[14]  J. Mascola,et al.  Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need? , 2009, Current opinion in HIV and AIDS.

[15]  G. Alter,et al.  Opportunities to exploit non-neutralizing HIV-specific antibody activity. , 2013, Current HIV research.

[16]  Huseyin Seker,et al.  Quantitative prediction of peptide binding affinity by using hybrid fuzzy support vector regression , 2016, Appl. Soft Comput..

[17]  Deng Cai,et al.  Unsupervised feature selection for multi-cluster data , 2010, KDD.

[18]  Huan Liu,et al.  Spectral feature selection for supervised and unsupervised learning , 2007, ICML '07.

[19]  G. Alter,et al.  Emerging concepts on the role of innate immunity in the prevention and control of HIV infection. , 2012, Annual review of medicine.

[20]  F. Pereyra,et al.  IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines. , 2010, AIDS research and human retroviruses.

[21]  Alexander J. Smola,et al.  Support Vector Regression Machines , 1996, NIPS.

[22]  Jerome H. Kim,et al.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.

[23]  Zhoujun Li,et al.  A novel unsupervised feature selection method for bioinformatics data sets through feature clustering , 2008, 2008 IEEE International Conference on Granular Computing.